ZEBRA TECHNOLOGIES CP ($ZBRA) posted quarterly earnings results on Tuesday, August 5th. The company reported earnings of $3.61 per share, beating estimates of $3.39 by $0.22. The company also reported revenue of $1,293,000,000, missing estimates of $1,312,339,058 by $-19,339,058.
You can see Quiver Quantitative's $ZBRA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ZEBRA TECHNOLOGIES CP Insider Trading Activity
ZEBRA TECHNOLOGIES CP insiders have traded $ZBRA stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ZBRA stock by insiders over the last 6 months:
- ANDERS GUSTAFSSON has made 2 purchases buying 3,227 shares for an estimated $1,000,242 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ZEBRA TECHNOLOGIES CP Hedge Fund Activity
We have seen 345 institutional investors add shares of ZEBRA TECHNOLOGIES CP stock to their portfolio, and 399 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MACQUARIE GROUP LTD removed 1,053,249 shares (-65.0%) from their portfolio in Q1 2025, for an estimated $297,606,037
- SCHRODER INVESTMENT MANAGEMENT GROUP removed 810,835 shares (-82.4%) from their portfolio in Q1 2025, for an estimated $229,109,537
- ALYESKA INVESTMENT GROUP, L.P. added 353,890 shares (+inf%) to their portfolio in Q1 2025, for an estimated $99,995,158
- SQUAREPOINT OPS LLC added 321,253 shares (+2512.7%) to their portfolio in Q1 2025, for an estimated $90,773,247
- BOSTON PARTNERS removed 307,246 shares (-24.4%) from their portfolio in Q1 2025, for an estimated $86,815,429
- BLACKROCK, INC. removed 263,723 shares (-5.8%) from their portfolio in Q1 2025, for an estimated $74,517,570
- VICTORY CAPITAL MANAGEMENT INC added 255,193 shares (+27.5%) to their portfolio in Q1 2025, for an estimated $72,107,334
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ZEBRA TECHNOLOGIES CP Congressional Stock Trading
Members of Congress have traded $ZBRA stock 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ZBRA stock by members of Congress over the last 6 months:
- REPRESENTATIVE KELLY MORRISON has traded it 4 times. They made 0 purchases and 4 sales worth up to $95,000 on 06/04.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ZEBRA TECHNOLOGIES CP Analyst Ratings
Wall Street analysts have issued reports on $ZBRA in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 07/14/2025
- UBS issued a "Buy" rating on 04/30/2025
- Needham issued a "Buy" rating on 04/30/2025
To track analyst ratings and price targets for ZEBRA TECHNOLOGIES CP, check out Quiver Quantitative's $ZBRA forecast page.
ZEBRA TECHNOLOGIES CP Price Targets
Multiple analysts have issued price targets for $ZBRA recently. We have seen 7 analysts offer price targets for $ZBRA in the last 6 months, with a median target of $325.0.
Here are some recent targets:
- Piyush Avasthy from Citigroup set a target price of $342.0 on 07/14/2025
- Richard Eastman from Baird set a target price of $367.0 on 07/14/2025
- Meta Marshall from Morgan Stanley set a target price of $280.0 on 05/28/2025
- Damian Karas from UBS set a target price of $410.0 on 04/30/2025
- James Ricchiuti from Needham set a target price of $325.0 on 04/30/2025
- Tim Long from Barclays set a target price of $263.0 on 04/30/2025
- Jamie Cook from Truist Securities set a target price of $254.0 on 04/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
